PhotonPharma Inc., a biopharmaceutical company pioneering personalized cancer immunotherapies, today announced that patient recruitment has opened for its Phase 1 clinical trial evaluating Innocell™ ...

In explaining the rationale behind the study, Tang and colleagues pointed out that despite the lack of level 1 evidence, MDT ...

World Cancer Day highlights the shared impact of cancer and the importance of staying engaged and connected across the cancer ...

Gastrointestinal (GI) cancers, such as colorectal, gastric, and pancreatic cancers, are among the most prevalent and deadly worldwide. Despite advances in treatment, these cancers often remain ...

The key alterations sought are FGFR3 activating mutations or fusions/rearrangements (“susceptible” alterations), for potential use of the FGFR inhibitor erdafitinib (Balversa), and HER2 IHC expression ...

Women vaccinated against human papillomavirus (HPV) at a young age might be able to limit cervical cancer screening to two or ...

Cancer biology is a rapidly evolving field, with pathology and biomarker research at the forefront of innovations in ...

A significant portion of the clinical management for ADCs involves addressing payload-dependent toxicities, with interstitial lung disease (ILD) being a notable safety concern and potentially serious ...

An interdisciplinary multi-center research team led by the LKS Faculty of Medicine (HKUMed) and Faculty of Dentistry at the ...

In this video, Azka Ali, MD, medical oncologist at the Cleveland Clinic Taussig Cancer Institute, highlights interesting ...

Research shows many adults in their 20s, 30s and 40s are being diagnosed with colorectal cancer, with incidence increasing ...

A groundbreaking study identifies a "master switch" molecule, miR-181d, that controls the chaotic behavior of glioblastoma cells.